Why Poseida Therapeutics Is Trading Higher By Around 100

Aug 3, 2022 · Poseida Therapeutics, Inc. PSTX shares jumped 99.6% to $4.85 as the company entered ... for the second quarter after the close of trading on Thursday, August 4, 2022. ... % …

CouponFollow Extension

6%
OFF

Why Poseida Therapeutics Is Trading Higher By Around 100

2 days from now

Aug 3, 2022 · Poseida Therapeutics, Inc. PSTX shares jumped 99.6% to $4.85 as the company entered ... for the second quarter after the close of trading on Thursday, August 4, 2022. ... % …

benzinga.com

$1
OFF

Why Poseida Therapeutics Shares Are Trading Higher By 219

2 days from now

1 day ago · Shares of Poseida Therapeutics, Inc. PSTX rose sharply in today's pre-market trading after the company agreed to be acquired by Roche in a $1.5 billion deal. Poseida Therapeutics …

benzinga.com

$50
OFF

Why Are Poseida Therapeutics Shares Moving Higher Today?

2 days from now

Aug 7, 2023 · Poseida Therapeutics Inc PSTX shares are trading higher after the company received a $50 million strategic investment by Astellas Pharma Inc ALMPY ALMPF.. The …

benzinga.com

$20
OFF

Where Poseida Therapeutics Stands With Analysts - Nasdaq

2 days from now

Nov 15, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Poseida Therapeutics, presenting an average target of $20.0, a high estimate of $20.00, and a low …

nasdaq.com

70%
OFF

Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% In One Week

2 days from now

Nov 12, 2024 · Over the past quarter, shares of Poseida Therapeutics, Inc. Have risen 25.34%, and are up 76.67% in the last year. On the other hand, the S&P 500 has only moved 12.69% …

nasdaq.com

8%
OFF

Why Poseida Therapeutics Shares Are Trading Higher By… - Inkl

2 days from now

1 day ago · Poseida Therapeutics shares jumped 218.8% to $9.12 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers. ZenaTech, Inc. …

inkl.com

219%
OFF

Why Poseida Therapeutics Shares Are Trading Higher By 219%; …

2 days from now

1 day ago · Shares of Poseida Therapeutics, Inc. NASDAQ:PSTX rose sharply in today's pre-market trading after the company agreed to be acquired by Roche in a $1.5 billion …

tradingview.com

49%
OFF

Poseida Therapeutics (PSTX) Stock Price, News & Analysis

2 days from now

5 days ago · Poseida Therapeutics scored higher than 49% of companies evaluated by MarketBeat, and ranked 273rd out of 946 stocks in the medical sector. Scores are calculated …

marketbeat.com

$1
OFF

Roche To Acquire Cell Therapy Maker Poseida Therapeutics In $1.5 ...

2 days from now

1 day ago · ZURICH (Reuters) - Switzerland's Roche will acquire its U.S. collaboration partner Poseida Therapeutics in a cash deal worth up to $1.5 billion, banking on complex immune cell …

usnews.com

$1
OFF

Roche To Acquire Poseida For Up To $1.5 Bln - Nasdaq

2 days from now

1 day ago · Roche and Poseida already work together on CAR-T cell therapies for blood cancers, and this deal strengthens their partnership which started in 2022. PSTX had closed its regular …

nasdaq.com

70%
OFF

PSTX Stock Quote Price And Forecast | CNN

2 days from now

Yesterday 10:59am ET Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B by Zacks Nov 12 12:00pm ET Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% in One Week: …

cnn.com

9%
OFF

Why Nutanix Shares Are Trading Higher By 9%; Here Are 20

2 days from now

7 hours ago · Cyclerion Therapeutics, Inc. CYCN rose 72.8% to $2.35 in pre-market trading. Infobird Co., Ltd IFBD gained 56% to $2.87 in pre-market trading after declining around 6% on …

benzinga.com

$3.07
OFF

Poseida Therapeutics Stock Price - Markets Insider

2 days from now

On Friday 11/08/2024 the closing price of the Poseida Therapeutics Inc Registered Shs share was $3.07 on BTT. Compared to the opening price on Friday 11/08/2024 on BTT of $3.13, this …

businessinsider.com

FAQs about Why Poseida Therapeutics Is Trading Higher By Around 100 Coupon?

How did poseida Therapeutics' stock perform in 2024?

Poseida Therapeutics' stock was trading at $3.36 on January 1st, 2024. Since then, PSTX stock has decreased by 18.2% and is now trading at $2.75. View the best growth stocks for 2024 here. How were Poseida Therapeutics' earnings last quarter? Poseida Therapeutics, Inc. (NASDAQ:PSTX) issued its quarterly earnings data on Monday, August, 5th. ...

How much did poseida Therapeutics raise in an IPO?

Poseida Therapeutics (PSTX) raised $150 million in an initial public offering on Friday, July 10th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. BofA Securities, Piper Sandler and William Blair served as the underwriters for the IPO. Who are Poseida Therapeutics' major shareholders? ...

Is poseida Therapeutics (PsTx) a real deal?

Poseida Therapeutics (NASDAQ: PSTX) is a cell-therapy-focused biotech that I covered with some optimism back in December 2023, with the company's pipeline showing early signs of being the real deal. ...

Who is poseida Therapeutics?

Poseida Therapeutics, a small-cap company with a market cap of $279 million, has developed a system to develop and manufacture CAR-T therapies, which alter a patient’s immune system cells to attack cancer cells. ...

Is poseida Therapeutics a good stock to buy?

Poseida Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. Poseida Therapeutics has only been the subject of 1 research reports in the past 90 days. Read more about Poseida Therapeutics' stock forecast and price target. ...

What is poseida Therapeutics Inc registered SS's market capitalization?

Poseida Therapeutics Inc Registered Shs's market capitalization is $298.93 M by 97.13 M shares outstanding. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Selling, General & Admin. Exp. * Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet ...